Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.4M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
20.4M
-
Shares change
-
+3.16M
-
Total reported value, excl. options
-
$296M
-
Value change
-
+$42.3M
-
Put/Call ratio
-
1.45
-
Number of buys
-
59
-
Number of sells
-
-65
-
Price
-
$14.50
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q1 2017
142 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q1 2017.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.4M shares
of 46.4M outstanding shares and own 44.04% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.52M shares), VANGUARD GROUP INC (2.18M shares), STATE STREET CORP (1.06M shares), DIMENSIONAL FUND ADVISORS LP (1.06M shares), FEDERATED INVESTORS INC /PA/ (1.05M shares), ROTHSCHILD ASSET MANAGEMENT INC (625K shares), ACADIAN ASSET MANAGEMENT LLC (571K shares), TEACHERS ADVISORS, LLC (543K shares), Bank of New York Mellon Corp (520K shares), and JPMORGAN CHASE & CO (518K shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.